Greenwood Capital Associates LLC Exact Sciences Corp Transaction History

Greenwood Capital Associates LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$57.56 - $82.54 $418,058 - $599,488	-7,263 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$72.5 - $100.68 $60,972 - $84,671	-841 Reduced 10.38%	7,263 $565,000
Q3 2021 Oct 27, 2021	BUY	$90.24 - $124.05 $6,497 - $8,931	72 Added 0.9%	8,104 $773,000
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $21,354 - $31,753	228 Added 2.92%	8,032 $999,000
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $27,393 - $36,427	-235 Reduced 2.92%	7,804 $1.03 Million
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $20,320 - $28,992	-204 Reduced 2.47%	8,039 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $285,992 - $400,083	3,922 Added 90.77%	8,243 $841,000
Q2 2020 Aug 12, 2020	SELL	$55.75 - $92.75 $75,485 - $125,583	-1,354 Reduced 23.86%	4,321 $376,000
Q1 2020 May 12, 2020	BUY	$37.9 - $104.44 $215,082 - $592,697	5,675 New	5,675 $329,000
Q4 2018 Feb 11, 2019	SELL	$56.04 - $82.66 $368,799 - $543,985	-6,581 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$48.29 - $80.6 $41,529 - $69,316	-860 Reduced 11.56%	6,581 $519,000
Q2 2018 Aug 07, 2018	BUY	$37.84 - $69.96 $281,567 - $520,572	7,441 New	7,441 $445,000

674

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.